BPI Ask the Expert Webinar: De‑Risking Commercial Biologics in a Volatile Market
May 26, 2026
Time: 11 am EDT | 8 am PDT | 5 pm CEST
Duration: 30 minutes
De‑Risking Commercial Biologics in a Volatile Market:
Aligning Capacity, Compliance, and Continuity at 1,000–2,000L Scale
As biologics programs enter Phase III and commercial production, manufacturing strategy becomes a defining factor in launch success. In today’s volatile global environment — shaped by geopolitical shifts, tariff exposure, and regional capacity constraints — late-stage teams must ensure their manufacturing platform supports not only scale, but compliance, inspection readiness, and long-term supply continuity.
This webcast will explore how to de-risk commercial biologics manufacturing at the 1,000–2,000L scale by aligning capacity planning, validation strategy, and operational resilience. Attendees will gain practical insight into building commercial-ready platforms that protect PPQ timelines, reduce disruption risk, and maintain flexibility as demand evolves.
Key Takeaways:
- How to assess facility and platform fit for Phase III and commercial programs
- Strategies to strengthen PPQ readiness and inspection outcomes
- Approaches to mitigating geopolitical and regional supply risks at commercial scale
- Infrastructure considerations that support scalable expansion while preserving validated operations.
Join Bora Biologics to explore how disciplined commercial platform design can protect capacity, compliance, and continuity in an increasingly uncertain market.
Please join us for this free, live Ask the Expert webcast. Make sure to register for the session – you’ll get access to the live presentation plus recordings to revisit the content anytime.
